M Maroske

Learn More
BACKGROUND Body mass index (BMI) has an impact on survival outcome in patients treated with aromatase inhibitors (AIs). Obesity is associated with an increased body aromatisation and may be a cause of insufficient estradiol depletion. METHODS Sixty-eight postmenopausal oestrogen receptor-positive patients with early breast cancer were prospectively(More)
  • 1